Launch of Lenacapavir in South Africa for HIV prevention South Africa Helped Create Lenacapavir, Gilead Should Not Decide Who Gets It
[vc_row css_animation="" row_type="row" use_row_as_full_screen_section="no" type="full_width" angled_section="no" text_align="left" background_image_as_pattern="without_pattern"][vc_column][vc_column_text]Background: South Africa is preparing to rollout lenacapavir, the innovative, game changing twice-yearly injectable HIV pre-exposure prophylaxis (PrEP) drug that was also researched in the Global South. On June 5, the President and the Health Minister will officially launch the roll-out of lenacapavir in South Africa in Secunda, billed as a 'historic event'. But...